Ind Swift Laboratories Limited, a active public limited company, was established on 04 January 1995 in Chandigarh, Chandigarh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24232CH1995PLC015553. Registered under ROC Roc Chandigarh. it is listed on BSE: 532305 and NSE: INDSWFTLAB. It has an authorized capital of ₹115.00 Cr and a paid-up capital of ₹81.61 Cr.
It upholds a compliant status. In 2024, it reported revenue of ₹1,272.63 Cr and a net worth of ₹922.24 Cr. Its leadership includes Neerja Chathley (Director), Rajinder Kumar Gupta (Director), Rishav Mehta (Whole-Time Director). Past directors included Gopal Munjal, Narinder Pal Singh, Sanjeev Rai Mehta. It holds ₹819.92 Cr open charges and ₹5,103.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 850, Shivalik Enclave, Nac, Manimajra, Chandigarh, Chandigarh, 160101.
L24232CH1995PLC015553
015553
04 January 1995
₹115.00 Cr
₹81.61 Cr
Roc Chandigarh
Listed (BSE: 532305, NSE: INDSWFTLAB)
Active
Explore comprehensive insights into Ind Swift Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neerja Chathley | Director | 10 May 2019 | Current |
| Rajinder Kumar Gupta | Director | 23 Jun 2021 | Current |
| Rishav Mehta | Whole-Time Director | 23 Mar 2010 | Current |
| Subodh Gupta | Director | 05 Jul 2025 | Current |
| Sahil Munjal | Whole-Time Director | 13 Feb 2020 | Current |
| Navrattan Munjal | Managing Director | 04 Jan 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Apr 2019 | Past |
| Pramod Abcsdd | Director | 09 Oct 2012 | Past |
| Pramod Abcsdd | Director | 23 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 09 Aug 2013 | Past |
| Pramod Abcsdd | Director | 07 Nov 2014 | Past |
| Pramod Abcsdd | Director | 23 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ind Swift Laboratories Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.37% increase. The company also saw a substantial improvement in profitability, with a 885.1% increase in profit. The company's net worth Soared by an impressive increase of 36.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Ind Swift Laboratories had a promoter holding of 42.01% and a public holding of 58.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,199,170,060.00
₹51,037,607,385.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Others | ₹815.68 Cr | Open |
| 29 Aug 2023 | Axis Bank Limited | ₹1.70 Cr | Open |
| 04 Aug 2023 | Others | ₹5.00 M | Open |
| 30 Jul 2011 | First Blue Home Finance Limited | ₹2.00 Cr | Open |
| 18 Nov 2004 | Centurian Bank Ltd. | ₹0.40 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ind Swift Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ind Swift Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ind Swift Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Subodh Gupta was appointed as a Director was appointed as a Director on 05 Jul 2025 & has been associated with this company since 5 months 22 days . was documented.
The activity Prabhat Khurana was appointed as a Additional Director was appointed as a Additional Director on 05 Jul 2025 & has been associated with this company since 5 months 22 days . was completed.
Progress on Ind Swift Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge registered on 21 Jun 2019 via Charge ID 100270484 with Idbi Trusteeship Services Limited was fully satisfied on 12 Apr 2024. was documented.
A charge registered on 05 Sep 2018 via Charge ID 100214960 with Others was fully satisfied on 05 Apr 2024. was recorded as a recent event.
The activity A charge registered on 05 Sep 2018 via Charge ID 100215281 with Others was fully satisfied on 05 Apr 2024. was completed.
IndiaRF will acquire the active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) business of Ind-Swift Labs for a consideration of Rs 1,650 crore. ET first reported on this transaction on July 21 this year. The acquisition will be done through Synthimed Labs, a portfolio company of India Resurgence Fund.
Earlier in July 2021, Ind-Swift Laboratories had agreed to sell its API business to PI Industries on a slump sale basis, for ₹1,530 crore. However, the deal had been terminated by PI Industries in November 2021. Incorporated in 1995, IISL is engaged in the manufacturing of APIs, advanced intermediates and providing Contract Research and Manufacturing Services (CRAMS). The company has three manufacturing facilities- two in Dera Bassi (including research facility), Punjab and one in Samba, Jammu & Kashmir..
The CIN of Ind Swift Laboratories Limited is L24232CH1995PLC015553.
Ind Swift Laboratories Limited is headquartered at Sco 850, Shivalik Enclave, Nac, Manimajra, Chandigarh, Chandigarh, 160101.
Ind Swift Laboratories Limited was incorporated on 04 January 1995.
The current directors of Ind Swift Laboratories Limited are
The primary industry of Ind Swift Laboratories Limited is Manufacturing.
Ind Swift Laboratories Limited is listed. It is listed on BSE: 532305 and NSE: INDSWFTLAB.
The authorized capital of Ind Swift Laboratories Limited is ₹115.00 Cr, and the paid-up capital is ₹81.61 Cr.
The compliance status of Ind Swift Laboratories Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX